CVRx director granted 8,720 shares, 11,182 options

CVRx, Inc. director Joseph P. Slattery reported compensation-related equity grants.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CVRx, Inc. director Joseph P. Slattery reported compensation-related equity grants. He received 8,720 shares of Common Stock at no cost and a stock option for 11,182 shares with an exercise price of $5.43 per share, expiring on June 1, 2036. The option vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders. After these grants, Slattery directly holds 39,365 Common shares. These are awards, not open-market purchases or sales.

Insider Trade Summary

Grant/Award: 19,902 shares

Grant/Award 2 txns

Insider SLATTERY JOSEPH P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	11,182	$0.00	$0.00
Grant/Award	Common Stock	8,720	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 11,182 contracts (Direct); Common Stock — 39,365 shares (Direct)

Footnotes (1)

F1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CVRx (CVRX) report for Joseph P. Slattery?

CVRx reported that director Joseph P. Slattery received 8,720 shares of Common Stock and a stock option for 11,182 shares as equity compensation. These Form 4 transactions reflect awards, not open-market buying or selling of CVRx shares.

How many CVRx shares does Joseph P. Slattery hold after this Form 4?

After the reported grants, Joseph P. Slattery directly holds 39,365 shares of CVRx Common Stock. This total includes the newly awarded 8,720 shares, highlighting the scale of his current equity stake as a company director.

What are the key terms of Joseph P. Slattery’s new CVRx stock option?

The new CVRx stock option covers 11,182 shares of Common Stock at an exercise price of $5.43 per share. It expires on June 1, 2036 and represents a long-dated incentive tied to future company performance and stock price.

When does Joseph P. Slattery’s CVRx stock option vest?

The stock option granted to Joseph P. Slattery vests on the earlier of June 1, 2027 or CVRx’s 2027 annual meeting of stockholders. This vesting schedule links his compensation to continued board service through that date.

Did Joseph P. Slattery buy or sell CVRx shares in the market?

The filing shows equity awards, not market trades. Slattery received 8,720 shares of Common Stock and an 11,182-share stock option as compensation grants, with no open-market purchases or sales reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/03/2026 - 06:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SLATTERY JOSEPH P

(Last)

(First)

(Middle)

9201 WEST BROADWAY AVE

SUITE 650

(Street)

MINNEAPOLIS

MINNESOTA

55445

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		A		8,720⁽¹⁾	A	$0	39,365	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$5.43	06/01/2026		A		11,182		⁽¹⁾	06/01/2036	Common Stock	11,182	$0	11,182	D

Explanation of Responses:

1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

	/s/ Amy C. Seidel, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR